My Path to Quit Tobacco

Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age21+
SponsorUniversity of Wisconsin, Madison

About this trial

The overarching goal of this program of research is to reduce smoking-related health disparities by increasing smoking cessation among Black adults. The goal of this research proposal is to determine whether more intensive, culturally specific, evidence-based interventions are more effective at promoting long-term cessation and other key patient-centered outcomes compared to the usual evidence-based standard of care: services provided by a state-run quitline. This study compares the relative effectiveness of three different treatments (Standard, Intensive, and Intensive Incentivized) on long-term smoking cessation (biochemically confirmed abstinence from combusted tobacco at 26-weeks post-target quit day) among Black adults who smoke and want to quit.

Eligibility criteria

Qualifiers

self-identify as Black

smoke cigarettes (greater than or equal to 1 cigarette on greater than or equal to 4 days/week)

motivated to quit smoking

willing to discontinue any non-study smoking cessation pharmacotherapy use during study treatment.

Disqualifiers

currently taking bupropion for non-smoking cessation reasons

Trial design

Treatments tested in this trial

  • Nicotine patch
  • Quitline Counseling Phone Calls
  • Counseling Sessions
  • Pathways to Freedom
  • Monetary Incentive

Treatment groups

1,550 Participants
are divided into 3 treatment groups

Locations

5
Arizona State University85004, PhoenixArizona, United States
Indiana University46202, IndianapolisIndiana, United States
University of Kansas Medical Center Research Institute, Inc66160, Kansas CityKansas, United States
Virginia Commonwealth University23298, RichmondVirginia, United States

Sponsors and collaborators

University of Wisconsin, Madison

Lead sponsor

Patient-Centered Outcomes Research Institute

Collaborator